Literature DB >> 11805134

Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection.

Xiping Zhao1, Zhen-Ya Tang, Bettina Klumpp, Guido Wolff-Vorbeck, Heidi Barth, Shoshana Levy, Fritz von Weizsäcker, Hubert E Blum, Thomas F Baumert.   

Abstract

Hepatitis C virus (HCV) is a major cause of chronic hepatitis worldwide, but the study of HCV infection has been hampered by the lack of an in vitro or in vivo small animal model. The tree shrew Tupaia belangeri is susceptible to infection with a variety of human viruses in vivo, including hepatitis viruses. We show that primary Tupaia hepatocytes can be infected with serum- or plasma-derived HCV from infected humans, as measured by de novo synthesis of HCV RNA, analysis of viral quasispecies evolution, and detection of viral proteins. Production of infectious virus could be demonstrated by passage to naive hepatocytes. To assess whether viral entry in Tupaia hepatocytes was dependent on the recently isolated HCV E2 binding protein CD81, we identified and characterized Tupaia CD81. Sequence analysis of cloned Tupaia cDNA revealed a high degree of homology between Tupaia and human CD81 large extracellular loops (LEL). Cellular binding of E2 and HCV infection could not be inhibited by anti-CD81 antibodies or soluble CD81-LEL, suggesting that viral entry can occur through receptors other than CD81. Thus, primary Tupaia hepatocytes provide a potential model for the study of HCV infection of hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11805134      PMCID: PMC150834          DOI: 10.1172/JCI13011

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  47 in total

Review 1.  Replication of hepatitis C virus.

Authors:  R Bartenschlager; V Lohmann
Journal:  J Gen Virol       Date:  2000-07       Impact factor: 3.891

2.  The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.

Authors:  M J Alter; D Kruszon-Moran; O V Nainan; G M McQuillan; F Gao; L A Moyer; R A Kaslow; H S Margolis
Journal:  N Engl J Med       Date:  1999-08-19       Impact factor: 91.245

3.  Structure-function analysis of hepatitis C virus envelope-CD81 binding.

Authors:  R Petracca; F Falugi; G Galli; N Norais; D Rosa; S Campagnoli; V Burgio; E Di Stasio; B Giardina; M Houghton; S Abrignani; G Grandi
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

Review 4.  Pathogenesis, natural history, treatment, and prevention of hepatitis C.

Authors:  T J Liang; B Rehermann; L B Seeff; J H Hoofnagle
Journal:  Ann Intern Med       Date:  2000-02-15       Impact factor: 25.391

5.  Functional characterization of intracellular and secreted forms of a truncated hepatitis C virus E2 glycoprotein.

Authors:  M Flint; J Dubuisson; C Maidens; R Harrop; G R Guile; P Borrow; J A McKeating
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

6.  Hepatitis C virus-like particles synthesized in insect cells as a potential vaccine candidate.

Authors:  T F Baumert; J Vergalla; J Satoi; M Thomson; M Lechmann; D Herion; H B Greenberg; S Ito; T J Liang
Journal:  Gastroenterology       Date:  1999-12       Impact factor: 22.682

7.  Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection.

Authors:  A Meola; A Sbardellati; B Bruni Ercole; M Cerretani; M Pezzanera; A Ceccacci; A Vitelli; S Levy; A Nicosia; C Traboni; J McKeating; E Scarselli
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

8.  Evaluation of hepatitis C virus glycoprotein E2 for vaccine design: an endoplasmic reticulum-retained recombinant protein is superior to secreted recombinant protein and DNA-based vaccine candidates.

Authors:  J M Heile; Y L Fong; D Rosa; K Berger; G Saletti; S Campagnoli; G Bensi; S Capo; S Coates; K Crawford; C Dong; M Wininger; G Baker; L Cousens; D Chien; P Ng; P Archangel; G Grandi; M Houghton; S Abrignani
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

9.  Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2.

Authors:  A Higginbottom; E R Quinn; C C Kuo; M Flint; L H Wilson; E Bianchi; A Nicosia; P N Monk; J A McKeating; S Levy
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

10.  Mutations in the p53 tumor suppressor gene in tree shrew hepatocellular carcinoma associated with hepatitis B virus infection and intake of aflatoxin B1.

Authors:  U S Park; J J Su; K C Ban; L Qin; E H Lee; Y I Lee
Journal:  Gene       Date:  2000-06-13       Impact factor: 3.688

View more
  34 in total

1.  Re-evaluation and in silico annotation of the Tupaia herpesvirus proteins.

Authors:  Udo Bahr; Gholamreza Darai
Journal:  Virus Genes       Date:  2004-01       Impact factor: 2.332

2.  Hepatitis B virus molecular biology and pathogenesis.

Authors:  R Jason Lamontagne; Sumedha Bagga; Michael J Bouchard
Journal:  Hepatoma Res       Date:  2016-07-01

Review 3.  Animal models for the study of hepatitis C virus infection and replication.

Authors:  Kristin L MacArthur; Catherine H Wu; George Y Wu
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

4.  Long-term propagation of tree shrew spermatogonial stem cells in culture and successful generation of transgenic offspring.

Authors:  Chao-Hui Li; Lan-Zhen Yan; Wen-Zan Ban; Qiu Tu; Yong Wu; Lin Wang; Rui Bi; Shuang Ji; Yu-Hua Ma; Wen-Hui Nie; Long-Bao Lv; Yong-Gang Yao; Xu-Dong Zhao; Ping Zheng
Journal:  Cell Res       Date:  2016-12-23       Impact factor: 25.617

5.  New Methods in Tissue Engineering: Improved Models for Viral Infection.

Authors:  Vyas Ramanan; Margaret A Scull; Timothy P Sheahan; Charles M Rice; Sangeeta N Bhatia
Journal:  Annu Rev Virol       Date:  2014-11       Impact factor: 10.431

6.  Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection.

Authors:  Yimin Tong; Yongzhe Zhu; Xueshan Xia; Yuan Liu; Yue Feng; Xian Hua; Zhihui Chen; Hui Ding; Li Gao; Yongzhi Wang; Mark A Feitelson; Ping Zhao; Zhong-Tian Qi
Journal:  J Virol       Date:  2010-12-22       Impact factor: 5.103

7.  Scavenger receptor class B type I and hepatitis C virus infection of primary tupaia hepatocytes.

Authors:  Heidi Barth; Raffaele Cerino; Mirko Arcuri; Marco Hoffmann; Peter Schürmann; Mohammed I Adah; Bettina Gissler; Xiping Zhao; Valeria Ghisetti; Bruna Lavezzo; Hubert E Blum; Fritz von Weizsäcker; Alessandra Vitelli; Elisa Scarselli; Thomas F Baumert
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

8.  Genome of the Chinese tree shrew.

Authors:  Yu Fan; Zhi-Yong Huang; Chang-Chang Cao; Ce-Shi Chen; Yuan-Xin Chen; Ding-Ding Fan; Jing He; Hao-Long Hou; Li Hu; Xin-Tian Hu; Xuan-Ting Jiang; Ren Lai; Yong-Shan Lang; Bin Liang; Sheng-Guang Liao; Dan Mu; Yuan-Ye Ma; Yu-Yu Niu; Xiao-Qing Sun; Jin-Quan Xia; Jin Xiao; Zhi-Qiang Xiong; Lin Xu; Lan Yang; Yun Zhang; Wei Zhao; Xu-Dong Zhao; Yong-Tang Zheng; Ju-Min Zhou; Ya-Bing Zhu; Guo-Jie Zhang; Jun Wang; Yong-Gang Yao
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

9.  Molecular anatomy of Tupaia (tree shrew) adenovirus genome; evolution of viral genes and viral phylogeny.

Authors:  Udo Bahr; Eva Schöndorf; Michaela Handermann; Gholamreza Darai
Journal:  Virus Genes       Date:  2003-08       Impact factor: 2.332

10.  Interaction of hepatitis C virus envelope glycoprotein E2 with the large extracellular loop of tupaia CD81.

Authors:  Zhan-Fei Tian; Hong Shen; Xi-Hua Fu; Yi-Chun Chen; Hubert E Blum; Thomas F Baumert; Xi-Ping Zhao
Journal:  World J Gastroenterol       Date:  2009-01-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.